The Pennant Group (NASDAQ:PNTG – Get Free Report) had its price target lowered by investment analysts at Truist Financial from $32.00 to $28.00 in a research note issued to investors on Friday,Benzinga reports. The firm currently has a “hold” rating on the stock. Truist Financial’s price objective indicates a potential upside of 25.81% from the company’s previous close.
Several other equities analysts also recently weighed in on the company. Wells Fargo & Company began coverage on The Pennant Group in a report on Thursday, December 19th. They set an “equal weight” rating and a $33.00 price target for the company. Oppenheimer increased their price objective on shares of The Pennant Group from $34.00 to $37.00 and gave the company an “outperform” rating in a research report on Friday, November 8th. Two equities research analysts have rated the stock with a hold rating and three have given a buy rating to the company. According to MarketBeat, The Pennant Group has an average rating of “Moderate Buy” and a consensus target price of $35.20.
Read Our Latest Report on PNTG
The Pennant Group Stock Down 3.7 %
Institutional Inflows and Outflows
Several hedge funds have recently modified their holdings of the business. Summit Global Investments purchased a new stake in shares of The Pennant Group during the third quarter valued at $254,000. Premier Fund Managers Ltd purchased a new stake in shares of The Pennant Group during the 3rd quarter valued at about $976,000. Connor Clark & Lunn Investment Management Ltd. purchased a new stake in shares of The Pennant Group during the 3rd quarter valued at about $363,000. Intech Investment Management LLC bought a new stake in shares of The Pennant Group in the third quarter worth approximately $232,000. Finally, Navellier & Associates Inc. purchased a new position in shares of The Pennant Group during the third quarter valued at approximately $874,000. Hedge funds and other institutional investors own 85.88% of the company’s stock.
The Pennant Group Company Profile
The Pennant Group, Inc provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families.
See Also
- Five stocks we like better than The Pennant Group
- Stock Market Sectors: What Are They and How Many Are There?
- These 3 Iconic Brands Just Announced Bigger Dividend Payouts
- How Can Investors Benefit From After-Hours Trading
- Zscaler: Bullish Pressure Builds, Rapid Price Increase Expected
- Stock Splits, Do They Really Impact Investors?
- 4 EV Stocks Facing Uncertainty—Which Ones Will Survive?
Receive News & Ratings for The Pennant Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Pennant Group and related companies with MarketBeat.com's FREE daily email newsletter.